Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 575 results for "fusion iii"

Celgene (CELG) Mark J. Alles on Q2 2016 Results - Earnings Cal...

Celgene Corp. (NASDAQ: CELG ) Q2 2016 Earnings Call July 28, 2016 9:00 am ET Executives Patrick E. Flanigan III - Corporate Vice President, Investor Relations Mark J. Alles - Chief Executive Officer & Director Peter N. Kellogg - ... Seeking Alpha, 1 month ago

5 images for fusion iii

Investing.com, 1 month ago
Investing.com, 2 months ago
Balita, 4 months ago
Birmingham Times, 4 months ago
4 Traders, 6 months ago

CANbridges CAN008 Approved for Phase III Trial in NewlyDiagnosed Glioblastoma Multiforme in Taiwan

CANbridge's CAN-008 Approved for Phase I/II Trial in Newly-Diagnosed Glioblastoma Multiforme in Taiwan Tuesday, July 26, 2016 BEIJING--( BUSINESS WIRE )-- CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug ...
 Asian Hospital & Healthcare Management1 month ago CANbridge receives Taiwan FDA approval to begin phase I/II study of CAN-008 in newly-diagnosed glioblastoma multiforme  PharmaBiz1 month ago CANbridge receives IND approval from TFDA for Phase I/II trial of CAN-008 to treat GBM  Drug Development Technology1 month ago CANbridge's CAN-008 Approved for Phase I/II Trial in Newly-Diagnosed Glioblastoma Multiforme in Taiwan  Business Wire1 month ago
[x]  

Differential Sensitivity to Crizotinib: Does EML4-ALK Fusion Variant Matter? [EDITORIAL]

2016 by American Society of Clinical Oncology Alice T. Shaw ⇑ Massachusetts General Hospital Cancer Center, Boston, MA Corresponding author: Alice T. Shaw, MD, PhD, Department of Thoracic Oncology, Massachusetts General Hospital Cancer ...
 Journal of Clinical Oncology1 month ago

San Antonio restaurant inspections: Worst reports from...

Photo: Google Fusion Tables Image 1 of / 61 Caption Close Image 1 of 61 These are the food establishments that had 14 or more demerits or a score of 89 or below on a health inspection in 2016. The following 59 food spots ...
 MySanAntonio1 month ago

Phosphorylation of residues inside the SNARE complex suppresses secretory vesicle fusion

Introduction Animal cells maintain tissue function by secreting regulatory factors to signal their activity and nutrient status, pathogen infections, or injury. These regulated vesicle fusion events are typically much slower than the Ca 2+ ...
 EMBO Journal1 month ago
Datacenter Dynamics

Akado achieves Tier III design certification in Moscow

Russian telecommunications specialist Akado Telecom has obtained Tier III Design Document certification from the Uptime Institute for its data center in Moscow. The certificate proves that the facility was designed to be concurrently ...
 Datacenter Dynamics1 month ago Akado data centre gets Tier-III certificate  Telecompaper1 month ago
Floor Trends

Ecore Receives Two Product Patents

Ecore recently received two product patents covering any surfaces Ecore creates that features an Ecore EPDM surface fusion bonded to an Ecore recycled rubber backing or any heterogeneous sheet vinyl surface fusion bonded to an Ecore recycled rubber ...
 Floor Trends2 months ago Ecore Receives Two U.S. Product Patents  Club Industry2 months ago

CSL Behring Presents Phase III Data for IDELVION® for Hemophilia B at the World Federation of Hemophilia 2016 World Congress

/PRNewswire/ -- CSL Behring today announced new data from its Phase III PROLONG-9FP clinical development program evaluating IDELVION® [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], the company's novel, long-acting recombinant ...
 Nasdaq1 month ago
[x]  

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) Pipeline Review, H1 2016 - Research and Markets

Research and Markets has announced the addition of the "C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016" report to their offering. C-C Chemokine Receptor Type 5 (C-C CKR-5 ...
 4 Traders1 month ago Multiple Sclerosis - Pipeline Review, H1 2016; New Report Launched  Digital Journal1 month ago Global Glycoprotein 41 (gp41) Pipeline Report 2016 - Research and Markets  BioSpace1 month ago Bromodomain and Extra-Terminal Domain Protein (BET) Inhibitors - Pipeline Insights, 2016; New Report Launched  Digital Journal1 month ago
[x]  

Celent Awards Alfa-Bank and Misys for Basel compliance project

"Misys FusionRisk has enabled us to make faster and more informed business decisions on behalf of our clients" - Martin Pilecky, CIO, Alfa-Bank. London, United Kingdom (PRWEB UK) 7 July 2016 Misys has been recognised for the second time in ...
 PRWeb1 month ago Alfa-Bank and Misys Basel Compliance Project Recognized by Celent Awards  RFPConnect1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less